10.6084/m9.figshare.6808256.v1
Rosarin Sruamsiri
Rosarin
Sruamsiri
Kosuke Iwasaki
Kosuke
Iwasaki
Wentao Tang
Wentao
Tang
Jรถrg Mahlich
Jรถrg
Mahlich
Additional file 1: of Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
Springer Nature
2018
Psoriasis
Biological therapy
Persistence
Medical costs
Real-world data
Claims database
2018-07-11 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Persistence_rates_and_medical_costs_of_biological_therapies_for_psoriasis_treatment_in_Japan_a_real-world_data_study_using_a_claims_database/6808256
Appendix A. ICD codes for disease to be excluded. Appendix B. Dosage regimen of included BTs. Appendix C. Gap definition (days) of included BTs in base case and sensitivity analysis (SA) 1 and 2. Appendix D. The rates of (number of persistent patients during the 12-month period after BT initiation/number of total patients) calculated in the base case and sensitivity analysis (SA) 1 and 2. (DOCX 23 kb)